Renal ultrasonography predicts worsening renal function in patients with heart failure under tolvaptan administration.
Nobukiyo TanakaYoshio FurukawaTakuya MaedaHiroki IshiharaKazuhiro DanMasanori TeramuraKei IchihashiTetsuro TakaseYuya TakahashiDaichi TsuzuraAkira ShinodaMasato FujiiHisashi OkadaFumiharu ItabashiTomohiko TeramotoPublished in: ESC heart failure (2024)
Tolvaptan increased the PSV and EDV of the interlobar artery, which may mean tolvaptan increased renal blood flow. The renal artery AT may be a surrogate for worsening renal function.